Research and Markets: Find out the Latest Financial Results of Merck Generics - the Major International Generic Manufacturer.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37923) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Merck Generics Company Intelligence Report to their offering. Our generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the companys active product lines and ANDA ANDA abbr. abbreviated new drug application approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . Topics Covered INTRODUCTION Alphapharm Generics (UK) Genpharm Merck Generics (South Africa South Africa, Afrikaans Suid-Afrika, officially Republic of South Africa, republic (2005 est. pop. 44,344,000), 471,442 sq mi (1,221,037 sq km), S Africa. ) Merck Generiques (France) Merck Dura Merck Hoei McDermott Laboratories (Gerard) Dey Inc PRODUCTS Alphapharm ANDA Approvals, 2002-05 Genpharm ANDA Approvals, 2002-05 Dey ANDA Approvals, 2002-05 Recent product approvals Zonisamide capsules Levothyroxine tablets Alphapharm receives cilostazol ANDA FINANCIAL RESULTS Latest Yearly Results, 2005 Merck KGaA This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Pharmaceutical Sales, 2000-05 (euro millions) Merck KGaA Pharmaceutical Sales, 2000-05 (% of Total) Merck KGaA Pharmaceutical Sales, 2001-05 (% Change) Merck Generics Financial Results, 2003-05 (euro millions) Merck Generics Sales by Region, 2004-05 (million euros) Profit after tax of major subsidiaries, 2003-05 (euros million) Employees of major subsidiaries, 2003-05 Major developments Expansion of McDermott Laboratories, Ireland Mergers, acquisitions and agreements Microbix takes over urokinase urokinase /uro·ki·nase/ (UK) (u?ro-ki´nas) u-plasminogen activator; an enzyme in the urine of humans and other mammals, elaborated by the parenchymal cells of the human kidney and acting as a plasminogen activator. production from Genpharm Merck KGaA purchases Spains Prasfarma Orbus and Generics (UK) sign cefuroxime axetil cefuroxime axetil (sef´yōōrok´sēm ak´s licensing and supply agreement MERCK GENERICS GENERIC COMPANIES ANALYSIS ii Quarter I, 2006 Inyx selected by Generics (UK) to produce salbutamol salbutamol /sal·bu·ta·mol/ (sal-bu´tah-mol) albuterol. sal·bu·ta·mol n. A sympathomimetic agent used as a bronchodilator, especially in the treatment of asthma. asthma inhaler Acquisition of NM Pharma Atrix Laboratories Mohan Generics Unit Litigation Dey files Para IV ANDA submission for levalbuterol inhalation solution Takeda wins patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. litigation against ANDA filers for generic Actos Alphapharm settles US litigation with Forest Laboratories, enters authorised generic agreement Generics (UK) Serious Fraud Office investigation NHS NHS abbr. National Health Service NHS (in Britain) National Health Service Legal Action, 2004 Summary The Merck Generics Group was formed as part of the German Merck KGaA group in 1994, and forms part of the company's Pharmaceuticals Division. The company has since grown to become a major international generic manufacturer. It is broadly represented across the world, and claims a leading position in the markets of Australia, France, New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. , Portugal, and the United Kingdom. Merck Generics' research and development strategy is to identify all major products across the world with a patent expiry in the near-future and ensure that they are available for sale in the relevant territories on the day of patent expiry. Merck Generics' subsidiaries include: --Merck Generiques (France) --Merck dura (Germany) --Merck Generics Italia (Italy) --Merck Generics (Netherlands) --Merck Generics (Spain) --Merck NM (Sweden) --Generics (UK) --Alphapharm (Australia) --Genpharm (Canada) --Merck Generics Brazil --Genpharm LP (USA) --Merck Hoei (Japan) --Merck Generics South Africa --Dey, inc (USA) --McDermott Laboratories (Ireland) For more information visit http://www.researchandmarkets.com/reports/c37923 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion